Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3054% above fair value
$23.67−0.37 (-1.54%)
Close on Nov 12, 2026Market cap $3.02BP/E 91.0Yield –
Earnings
Privia Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$657.00M
+13.2% on a year earlier
Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted, Q3 FY2026
$0.21
$0.29 a year earlier
Latest guidance
Raised
Nov 5, 2026 · 6 items
Quarterly results
Revenue and earnings per share from each of Privia Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026before the open | $657.00M | +13.2% | $0.10 | $0.21 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026before the open | $632.60M | +21.4% | $0.07 | $0.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026before the open | $603.80M | +25.8% | $0.02 | $0.19 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $541.20M | – | $0.07 | $0.25 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025before the open | $580.40M | – | $0.05 | $0.29 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | $521.20M | +23.4% | $0.02 | $0.24 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | $480.10M | +15.6% | $0.03 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025before the open | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $422.30M | +2.2% | $0.03 | $0.19 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | $415.20M | +7.5% | $0.02 | $0.18 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024before the open | $440.80M | +21.0% | $0.02 | $0.15 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 3, 2023before the open | $417.30M | +21.7% | $0.05 | $0.17 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $413.40M | +23.2% | $0.06 | $0.17 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $386.30M | +23.1% | $0.06 | $0.16 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023before the open | $364.40M | +32.4% | $0.14 | $0.13 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | $342.90M | +36.3% | $0.01 | $0.13 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | $335.50M | – | -$0.10 | $0.13 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | $313.80M | – | -$0.16 | $0.12 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 22, 2022after the close | $275.30M | – | -$0.11 | $0.06 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 8, 2021before the open | $251.50M | – | -$0.09 | $0.13 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 9, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 27, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Privia Health's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| GAAP RevenueGAAP | FY2026 | $2.50B – $2.55B | – | New | Nov 5, 2026 |
| GAAP RevenueGAAP | FY2026 | $2.35B – $2.45B | $2.35B – $2.45B | Reaffirmed | May 7, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $154.00M – $157.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $145.00M – $155.00M | $145.00M – $155.00M | Reaffirmed | May 7, 2026 |
| Adjusted EBITDA to convert to free cash flownon-GAAP | FY2026 | 70% – 80% | – | New | Aug 6, 2026 |
| Attributed Lives | FY2026 | 1,675,000 – 1,690,000 | – | New | Nov 5, 2026 |
| Attributed Livesnon-GAAP | FY2026 | 1,625,000 – 1,650,000 | – | New | Aug 6, 2026 |
| Attributed Lives | FY2026 | 1,600,000 – 1,625,000 | 1,550,000 – 1,600,000 | Raised | May 7, 2026 |
| Care Marginnon-GAAP | FY2026 | $535.00M – $540.00M | – | New | Nov 5, 2026 |
| Care Marginnon-GAAP | FY2026 | $515.00M – $530.00M | $515.00M – $530.00M | Raised | May 7, 2026 |
| Implemented Providers | FY2026 | 5900 – 6000 | 5900 – 6000 | Lowered | May 7, 2026 |
| Platform Contributionnon-GAAP | FY2026 | $280.00M – $285.00M | – | Lowered | Nov 5, 2026 |
| Platform Contributionnon-GAAP | FY2026 | $260.00M – $270.00M | $260.00M – $270.00M | Lowered | May 7, 2026 |
| Practice Collectionsnon-GAAP | FY2026 | $3.90B – $3.95B | – | Raised | Nov 5, 2026 |
| Practice Collections | FY2026 | $3.65B – $3.75B | $3.65B – $3.75B | Reaffirmed | May 7, 2026 |
Guidance vs results
The last range Privia Health gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $2.05B – $2.10B | $2.12BΣ4Q | Above range |
Guidance history
Every forecast Privia Health put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Adjusted EBITDA | FY2026 | $154.00M – $157.00M | New |
| Nov 5, 2026 | Platform Contribution | FY2026 | $280.00M – $285.00M | Lowered |
| Nov 5, 2026 | Care Margin | FY2026 | $535.00M – $540.00M | New |
| Nov 5, 2026 | Attributed Lives | FY2026 | 1,675,000 – 1,690,000 | New |
| Nov 5, 2026 | Practice Collections | FY2026 | $3.90B – $3.95B | Raised |
| Nov 5, 2026 | GAAP Revenue | FY2026 | $2.50B – $2.55B | New |
| Aug 6, 2026 | Adjusted EBITDA to convert to free cash flow | FY2026 | 70% – 80% | New |
| Aug 6, 2026 | Attributed Lives | FY2026 | 1,625,000 – 1,650,000 | New |
| May 7, 2026 | Adjusted EBITDA | FY2026 | $145.00M – $155.00M | Reaffirmed |
| May 7, 2026 | Implemented Providers | FY2026 | 5900 – 6000 | Lowered |
| May 7, 2026 | Attributed Lives | FY2026 | 1,600,000 – 1,625,000 | Raised |
| May 7, 2026 | Practice Collections | FY2026 | $3.65B – $3.75B | Reaffirmed |
| May 7, 2026 | Care Margin | FY2026 | $515.00M – $530.00M | Raised |
| May 7, 2026 | Platform Contribution | FY2026 | $260.00M – $270.00M | Lowered |
| May 7, 2026 | GAAP Revenue | FY2026 | $2.35B – $2.45B | Reaffirmed |
| Feb 26, 2026 | Adjusted EBITDA | FY2026 | $145.00M – $155.00M | New |
| Feb 26, 2026 | Practice Collections | FY2026 | $3.65B – $3.75B | New |
| Feb 26, 2026 | Implemented Providers | FY2026 | 5900 – 6000 | New |
| Feb 26, 2026 | Attributed Lives | FY2026 | 1,550,000 – 1,600,000 | Raised |
| Feb 26, 2026 | Care Margin | FY2026 | $515.00M – $530.00M | New |
| Feb 26, 2026 | Platform Contribution | FY2026 | $260.00M – $270.00M | Lowered |
| Feb 26, 2026 | GAAP Revenue | FY2026 | $2.35B – $2.45B | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $118.00M – $121.00M | New |
| Nov 6, 2025 | Implemented Providers | FY2025 | 5300 – 5350 | New |
| Nov 6, 2025 | Attributed Lives | FY2025 | 1,400,000 – 1,425,000 | Raised |
| Nov 6, 2025 | Practice Collections | FY2025 | $3.45B – $3.50B | New |
| Nov 6, 2025 | Care Margin | FY2025 | $455.00M – $460.00M | New |
| Nov 6, 2025 | Platform Contribution | FY2025 | $230.00M – $235.00M | Lowered |
| Nov 6, 2025 | GAAP Revenue | FY2025 | $2.05B – $2.10B | New |
| May 8, 2025 | Adjusted EBITDA | FY2025 | $105.00M – $110.00M | New |
| May 8, 2025 | Implemented Providers | FY2025 | 5200 – 5300 | New |
| May 8, 2025 | Attributed Lives | FY2025 | 1,300,000 – 1,400,000 | Raised |
| May 8, 2025 | Effective tax rate | FY2025 | 26% – 28% | New |
| May 8, 2025 | Practice Collections | FY2025 | $3.15B – $3.25B | New |
| May 8, 2025 | Care Margin | FY2025 | $435.00M – $445.00M | New |
| May 8, 2025 | Platform Contribution | FY2025 | $208.00M – $218.00M | Lowered |
| May 8, 2025 | GAAP Revenue | FY2025 | $1.80B – $1.90B | New |
| Nov 7, 2024 | Capital expenditures | FY2024 | $1.00M | New |
| Aug 8, 2024 | Adjusted EBITDA | FY2024 | $85.00M – $90.00M | Reaffirmed |
| Aug 8, 2024 | Care Margin | FY2024 | $388.00M – $400.00M | New |
| Aug 8, 2024 | Implemented Providers | FY2024 | 4650 – 4750 | Lowered |
| Aug 8, 2024 | Attributed Lives | FY2024 | 1,150,000 – 1,200,000 | Raised |
| Aug 8, 2024 | Practice Collections | FY2024 | $2.78B – $2.88B | Raised |
| Aug 8, 2024 | Platform Contribution | FY2024 | $180.00M – $188.00M | Lowered |
| Aug 8, 2024 | GAAP Revenue | FY2024 | $1.60B – $1.68B | Reaffirmed |
| May 9, 2024 | Adjusted EBITDA | FY2024 | $85.00M – $90.00M | Reaffirmed |
| May 9, 2024 | Implemented Providers | FY2024 | 4650 – 4750 | Lowered |
| May 9, 2024 | Attributed Lives | FY2024 | 1,150,000 – 1,200,000 | Raised |
| May 9, 2024 | Effective tax rate | FY2024 | 27% – 28% | Reaffirmed |
| May 9, 2024 | Practice Collections | FY2024 | $2.78B – $2.88B | Raised |
| May 9, 2024 | Care Margin | FY2024 | $388.00M – $400.00M | Lowered |
| May 9, 2024 | Platform Contribution | FY2024 | $180.00M – $188.00M | Lowered |
| May 9, 2024 | GAAP Revenue | FY2024 | $1.60B – $1.68B | Reaffirmed |
| Feb 27, 2024 | Adjusted EBITDA | FY2024 | $85.00M – $90.00M | New |
| Feb 27, 2024 | Implemented Providers | FY2024 | 4650 – 4750 | New |
| Feb 27, 2024 | Attributed Lives | FY2024 | 1,150,000 – 1,200,000 | Raised |
| Feb 27, 2024 | Effective tax rate | FY2024 | 27% – 28% | New |
| Feb 27, 2024 | Practice Collections | FY2024 | $2.78B – $2.88B | New |
| Feb 27, 2024 | Care Margin | FY2024 | $388.00M – $400.00M | New |
| Feb 27, 2024 | Platform Contribution | FY2024 | $180.00M – $188.00M | Lowered |
| Feb 27, 2024 | GAAP Revenue | FY2024 | $1.60B – $1.68B | New |
| Nov 3, 2023 | Adjusted EBITDA | FY2023 | $70.00M – $74.00M | Reaffirmed |
| Nov 3, 2023 | Care Margin | FY2023 | $350.00M – $365.00M | New |
| Nov 3, 2023 | Implemented Providers | FY2023 | 4050 – 4150 | Lowered |
| Nov 3, 2023 | Attributed Lives | FY2023 | 1,050,000 – 1,150,000 | Raised |
| Nov 3, 2023 | Practice Collections | FY2023 | $2.70B – $2.85B | New |
| Nov 3, 2023 | Platform Contribution | FY2023 | $160.00M – $168.00M | Lowered |
| Nov 3, 2023 | GAAP Revenue | FY2023 | $1.55B – $1.65B | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $70.00M – $74.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA expected to convert to free cash flow | FY2023 | 80% – 90% | Reaffirmed |
| Aug 3, 2023 | Implemented Providers | FY2023 | 4050 – 4150 | Lowered |
| Aug 3, 2023 | Attributed Lives | FY2023 | 1,050,000 – 1,150,000 | Raised |
| Aug 3, 2023 | Care Margin | FY2023 | $350.00M – $365.00M | Raised |
| Aug 3, 2023 | Platform Contribution | FY2023 | $160.00M – $168.00M | Lowered |
| Aug 3, 2023 | Practice Collections | FY2023 | $2.70B – $2.85B | Raised |
| Aug 3, 2023 | GAAP Revenue | FY2023 | $1.55B – $1.65B | Reaffirmed |
| May 4, 2023 | Adjusted EBITDA | FY2023 | $70.00M – $74.00M | Reaffirmed |
| May 4, 2023 | Implemented Providers | FY2023 | 4050 – 4150 | Lowered |
| May 4, 2023 | Attributed Lives | FY2023 | 1,050,000 – 1,150,000 | Raised |
| May 4, 2023 | Practice Collections | FY2023 | $2.70B – $2.85B | Raised |
| May 4, 2023 | Care Margin | FY2023 | $350.00M – $365.00M | Lowered |
| May 4, 2023 | Platform Contribution | FY2023 | $160.00M – $168.00M | Lowered |
| May 4, 2023 | GAAP Revenue | FY2023 | $1.55B – $1.65B | Reaffirmed |
| Feb 28, 2023 | Capital expenditures | FY2023 | $1.00M | New |
| Feb 28, 2023 | Adjusted EBITDA | FY2023 | $70.00M – $74.00M | New |
| Feb 28, 2023 | Adjusted EBITDA expected to convert to free cash flow | FY2023 | 80% – 90% | New |
| Feb 28, 2023 | Implemented Providers | FY2023 | 4050 – 4150 | New |
| Feb 28, 2023 | Attributed Lives | FY2023 | 1,050,000 – 1,150,000 | Raised |
| Feb 28, 2023 | Practice Collections | FY2023 | $2.70B – $2.85B | New |
| Feb 28, 2023 | Care Margin | FY2023 | $350.00M – $365.00M | Lowered |
| Feb 28, 2023 | Platform Contribution | FY2023 | $160.00M – $168.00M | Lowered |
| Feb 28, 2023 | GAAP Revenue | FY2023 | $1.55B – $1.65B | New |
| Nov 10, 2022 | Adjusted EBITDA | FY2022 | $59.00M – $61.00M | Raised |
| Nov 10, 2022 | Implemented Providers | FY2022 | 3660 – 3680 | Lowered |
| Nov 10, 2022 | Attributed Lives | FY2022 | 850,000 – 860,000 | Raised |
| Nov 10, 2022 | Practice Collections | FY2022 | $2.33B – $2.40B | New |
| Nov 10, 2022 | Care Margin | FY2022 | $295.00M – $305.00M | Raised |
| Nov 10, 2022 | Platform Contribution | FY2022 | $142.00M – $146.00M | Lowered |
| Nov 10, 2022 | GAAP Revenue | FY2022 | $1.30B – $1.34B | Raised |
| Aug 11, 2022 | Capital expenditures | FY2022 | $1.00M | Reaffirmed |
| May 12, 2022 | Capital expenditures | FY2022 | $1.00M | New |
| May 12, 2022 | Adjusted EBITDA | FY2022 | $52.00M – $56.00M | Reaffirmed |
| May 12, 2022 | Implemented Providers | FY2022 | 3625 – 3725 | Lowered |
| May 12, 2022 | Attributed Lives | FY2022 | 860,000 – 890,000 | Raised |
| May 12, 2022 | Practice Collections | FY2022 | $2.05B – $2.20B | Raised |
| May 12, 2022 | Care Margin | FY2022 | $280.00M – $295.00M | Lowered |
| May 12, 2022 | Platform Contribution | FY2022 | $130.00M – $135.00M | Lowered |
| May 12, 2022 | GAAP Revenue | FY2022 | $1.23B – $1.30B | Reaffirmed |
| Mar 22, 2022 | Adjusted EBITDA | FY2022 | $52.00M – $56.00M | New |
| Mar 22, 2022 | Implemented Providers | FY2022 | 3625 – 3725 | New |
| Mar 22, 2022 | Attributed Lives | FY2022 | 860,000 – 890,000 | Raised |
| Mar 22, 2022 | Platform Contribution | FY2022 | $130.00M – $135.00M | Lowered |
| Mar 22, 2022 | Practice Collections | FY2022 | $2.05B – $2.20B | New |
| Mar 22, 2022 | Care Margin | FY2022 | $280.00M – $295.00M | Lowered |
| Mar 22, 2022 | GAAP Revenue | FY2022 | $1.23B – $1.30B | New |
| Nov 8, 2021 | Adjusted EBITDA | FY2021 | $39.00M – $41.00M | New |
| Nov 8, 2021 | Implemented Providers | FY2021 | 3300 – 3330 | New |
| Nov 8, 2021 | Attributed Lives | FY2021 | 760,000 – 765,000 | Raised |
| Nov 8, 2021 | Practice Collections | FY2021 | $1.52B – $1.54B | New |
| Nov 8, 2021 | Platform Contribution | FY2021 | $102.00M – $105.00M | Lowered |
| Nov 8, 2021 | Care Margin | FY2021 | $225.00M – $230.00M | Lowered |
| Nov 8, 2021 | GAAP Revenue | FY2021 | $900.00M – $920.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Privia Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- News
- Update
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
See a number that looks wrong?